GILEAD SCIENCES, INC. — Director's Dealing 2015

Dec 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-12-15

Reporting Person: BISCHOFBERGER NORBERT W (EVP, R&D and CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-15	Common Stock	M	43600	$23.755	Acquired	171536	Direct
2015-12-15	Common Stock	M	26400	$19.085	Acquired	197936	Direct
2015-12-15	Common Stock	S	30431	$102.6571	Disposed	167505	Direct
2015-12-15	Common Stock	S	39569	$102.2210	Disposed	127936	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-15	Non-Qualified Stock Option (right to buy)	$19.085	M	26400	Disposed	2021-01-20	Common Stock (26400)	Direct
2015-12-15	Non-Qualified Stock Option (right to buy)	$23.755	M	43600	Disposed	2020-01-28	Common Stock (43600)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $101.46 to $102.45. Full information regarding the number of shares purchased or sold at each separate p2rice will be provided to the SEC, the issuer or its shareowners upon request

F4: Sale prices reported for the transactions reported here range from $102.46 to $102.99. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.